{ "url": "https://allermi-site.vercel.app/allermi/allermi-vs-sensimist/", "collection": "allermi", "slug": "allermi-vs-sensimist", "frontmatter": { "title": "Allermi vs Sensimist: Compounded Rx vs Gentlest OTC", "description": "Sensimist (fluticasone furoate, 2+) vs Allermi's compounded 4-ingredient telehealth Rx.", "lastReviewed": "2026-04-28T00:00:00.000Z", "firstPublished": "2026-04-21T00:00:00.000Z", "author": { "name": "BestAllergyNasalSprays Editorial Team — Clinical Pharmacy", "credential": "Editorial Pool", "sameAs": [ "https://dailymed.nlm.nih.gov/", "https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers" ] }, "medicalReviewer": { "name": "BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology", "credential": "Editorial Pool", "sameAs": [ "https://www.aaaai.org/", "https://www.acaai.org/" ] }, "primaryKeyword": "allermi vs sensimist", "ymylTier": "medium", "citations": [], "tldr": "Sensimist (OTC fluticasone furoate 27.5 mcg) is approved ages 2+, scent-free, alcohol-free, the gentlest of the Flonase line. Allermi uses triamcinolone as its steroid component and adds 1–3 other actives. Sensimist is the better pediatric or sensitive-user starting point; Allermi is 13+ (in most states) multi-mechanism escalation option.", "claims": [ "c-002", "c-009", "c-010", "c-011", "c-033" ], "draft": false, "speakableSelectors": [ ".answer-box", ".claim", "h1", "h2" ], "takeaways": [ { "text": "Sensimist = OTC, 2+, scent-free, alcohol-free", "tier": "fda-label" }, { "text": "Allermi = Rx, 13+ in most states, multi-ingredient compounded", "tier": "fda-label" }, { "text": "Allermi not prescribed in pregnancy, breastfeeding, or under 13", "tier": "expert" } ], "related": [ { "href": "/reviews/sensimist/", "label": "Sensimist review", "kind": "Product", "description": "OTC fluticasone furoate, 2+, scent-free." }, { "href": "/reviews/allermi/", "label": "Allermi review", "kind": "Product", "description": "Compounded 4-active adult-only Rx." }, { "href": "/allermi/allermi-vs-flonase/", "label": "Allermi vs Flonase", "kind": "Head-to-head", "description": "Same question with regular Flonase propionate." }, { "href": "/compare/flonase-vs-sensimist/", "label": "Flonase vs Sensimist", "kind": "Head-to-head", "description": "The Flonase line internal comparison." }, { "href": "/demographic/kids/", "label": "Nasal sprays for kids", "kind": "Demographic", "description": "Allermi is 13+ in most states; Sensimist covers 2+; both available to most adolescents in most US states." }, { "href": "/symptom/congestion/", "label": "Best nasal spray for congestion", "kind": "Symptom", "description": "Both fit chronic-congestion picks in their age bands." } ], "competitor": { "id": "flonase-sensimist", "name": "Flonase Sensimist" } }, "outline": [], "evidenceCounts": { "metaAnalysis": 0, "rct": 0, "guideline": 1, "fdaLabel": 2, "cohort": 0, "expert": 2 }, "claimIds": [ "c-002", "c-009", "c-010", "c-011", "c-033" ], "body": "import Claim from '../../components/Claim.astro';\nimport CitationList from '../../components/CitationList.astro';\n\n\n\nFlonase Sensimist (fluticasone furoate 27.5 mcg/spray) is FDA-labeled for OTC use in adults and children 2 years of age and older; the eye-symptom indication on the label is restricted to ages 12 and older Triamcinolone is an intranasal corticosteroid that reduces nasal inflammation by suppressing the production of inflammatory mediators (cytokines, prostaglandins, leukotrienes) involved in allergic rhinitis. With consistent daily use it gradually controls the inflammation that drives congestion and other nasal symptoms Each active ingredient in Allermi is individually FDA-approved for the treatment of rhinitis. Allermi formulations are prepared by a state-licensed compounding pharmacy under the federal Food, Drug, and Cosmetic Act (section 503A); compounded drug products themselves are not FDA-approved as fixed-dose combinations and are primarily overseen by state pharmacy boards, with FDA conducting surveillance and for-cause inspections Allermi is currently available to eligible patients ages 13 and older across most US states Allermi is not currently prescribed during pregnancy or breastfeeding\n\n", "claims": [ { "id": "c-002", "claim": "Triamcinolone is an intranasal corticosteroid that reduces nasal inflammation by suppressing the production of inflammatory mediators (cytokines, prostaglandins, leukotrienes) involved in allergic rhinitis. With consistent daily use it gradually controls the inflammation that drives congestion and other nasal symptoms", "allermi_claim_id": "A2", "source_type": "StatPearls", "confidence": "high", "product_ids": [ "allermi", "nasacort" ], "ymyl_tier": "medium", "physician_signoff": "BestAllergyNasalSprays Team", "source_url": "https://www.ncbi.nlm.nih.gov/books/NBK544309/" }, { "id": "c-009", "claim": "Allermi is not currently prescribed during pregnancy or breastfeeding", "allermi_claim_id": "C2", "source_type": "allermi-library", "confidence": "high", "product_ids": [ "allermi" ], "ymyl_tier": "hard", "physician_signoff": "BestAllergyNasalSprays Team", "source_url": "https://www.allermi.com/pages/eligibility" }, { "id": "c-010", "claim": "Allermi is currently available to eligible patients ages 13 and older across most US states", "allermi_claim_id": "C1", "source_type": "allermi-library", "confidence": "high", "product_ids": [ "allermi" ], "ymyl_tier": "soft", "source_url": "https://www.allermi.com/pages/eligibility" }, { "id": "c-011", "claim": "Each active ingredient in Allermi is individually FDA-approved for the treatment of rhinitis. Allermi formulations are prepared by a state-licensed compounding pharmacy under the federal Food, Drug, and Cosmetic Act (section 503A); compounded drug products themselves are not FDA-approved as fixed-dose combinations and are primarily overseen by state pharmacy boards, with FDA conducting surveillance and for-cause inspections", "allermi_claim_id": "B3", "source_url": "https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers", "source_type": "FDA", "confidence": "high", "product_ids": [ "allermi" ], "ymyl_tier": "hard", "physician_signoff": "BestAllergyNasalSprays Team (legal-reviewed)" }, { "id": "c-033", "claim": "Flonase Sensimist (fluticasone furoate 27.5 mcg/spray) is FDA-labeled for OTC use in adults and children 2 years of age and older; the eye-symptom indication on the label is restricted to ages 12 and older", "source_url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=107100af-7ca2-44e8-b067-c0ab0a19a6dc", "source_type": "FDA-label", "confidence": "high", "product_ids": [ "sensimist" ], "ymyl_tier": "soft" } ] }